Quercetin in the Prevention of Covid-19 Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-12

Study Completion Date

2021-05-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Quercetin is a flavonol, a subclass of flavonoid compounds. Of the flavonol molecules, quercetin is the most abundant in fruit and vegetables. Quercetin flavonol is characterized by 3 crucial properties: antioxidant, anti-inflammatory and immunomodulatory. The combination of these 3 properties makes quercetin an excellent candidate for dealing with situations in which oxidative stress, inflammation and the immune system are involved. The purpose of the study is to evaluate the effectiveness of an oral nutritional supplement based on quercetin in the prevention of Covid-19 infection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early Mild Symptoms of COVID-19

NCT04861298

COVID-19

COMPLETED NA

Biological Effects of Quercetin in COPD

NCT03989271

Chronic Obstructive Pulmonary Disease

UNKNOWN PHASE1/PHASE2

Biological Effects of Quercetin in COPD Phase II

NCT06003270

Chronic Obstructive Pulmonary Disease Emphysema Chronic Bronchitis With Airway Obstruction

RECRUITING PHASE2

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)

NCT04851821

a Randomized Double-blind Study Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) PHYTOTHERAPIE

COMPLETED PHASE1

Effect of Quercetin on Prophylaxis and Treatment of COVID-19

NCT04377789

COVID-19

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

Group Type ACTIVE_COMPARATOR

Quercetin

Intervention Type DIETARY_SUPPLEMENT

Quercetin (500 mg), 2 times a day for 3 months

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type COMBINATION_PRODUCT

500 mg, 2 times a day for 3 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quercetin

Quercetin (500 mg), 2 times a day for 3 months

Intervention Type DIETARY_SUPPLEMENT

Placebo

500 mg, 2 times a day for 3 months

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Absence of Covid-19 infection

Exclusion Criteria

* Previous Sars-Cov-2 infection demonstrated with antibody positivity through venous sampling
* Demonstrated presence of Sars-Cov-2 through a nasopharyngeal antigenic swab before the start of oral nutritional supplementation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes